ZA988585B - Pharmaceutical compositions containing plasma protein. - Google Patents
Pharmaceutical compositions containing plasma protein.Info
- Publication number
- ZA988585B ZA988585B ZA9808585A ZA988585A ZA988585B ZA 988585 B ZA988585 B ZA 988585B ZA 9808585 A ZA9808585 A ZA 9808585A ZA 988585 A ZA988585 A ZA 988585A ZA 988585 B ZA988585 B ZA 988585B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- plasma protein
- containing plasma
- protein
- Prior art date
Links
- 102000004506 Blood Proteins Human genes 0.000 title 1
- 108010017384 Blood Proteins Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9701554A HUP9701554D0 (en) | 1997-09-18 | 1997-09-18 | Pharmaceutical composition containing plazma proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA988585B true ZA988585B (en) | 2000-03-13 |
Family
ID=90014222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9808585A ZA988585B (en) | 1997-09-18 | 1998-09-18 | Pharmaceutical compositions containing plasma protein. |
Country Status (33)
| Country | Link |
|---|---|
| US (5) | US6743826B1 (sl) |
| EP (1) | EP0981375B1 (sl) |
| JP (1) | JP2001508806A (sl) |
| KR (1) | KR100587962B1 (sl) |
| CN (1) | CN1189216C (sl) |
| AR (1) | AR017120A1 (sl) |
| AT (1) | ATE230611T1 (sl) |
| AU (1) | AU734695B2 (sl) |
| BG (1) | BG64749B1 (sl) |
| BR (1) | BR9812469A (sl) |
| CA (1) | CA2269923C (sl) |
| CZ (1) | CZ301326B6 (sl) |
| DE (1) | DE69810612T2 (sl) |
| DK (1) | DK0981375T3 (sl) |
| EA (1) | EA004700B1 (sl) |
| ES (1) | ES2187062T3 (sl) |
| HR (1) | HRP980499A2 (sl) |
| HU (1) | HUP9701554D0 (sl) |
| IL (1) | IL135055A (sl) |
| LT (1) | LT4736B (sl) |
| LV (1) | LV12493B (sl) |
| NO (1) | NO325294B1 (sl) |
| NZ (1) | NZ503302A (sl) |
| PL (1) | PL193067B1 (sl) |
| PT (1) | PT981375E (sl) |
| RO (1) | RO118695B1 (sl) |
| RS (1) | RS50102B (sl) |
| SI (1) | SI20189B (sl) |
| SK (1) | SK284683B6 (sl) |
| TR (1) | TR200001545T2 (sl) |
| TW (1) | TWI222365B (sl) |
| WO (1) | WO1999013914A1 (sl) |
| ZA (1) | ZA988585B (sl) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5439686A (en) * | 1993-02-22 | 1995-08-08 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor |
| US8137684B2 (en) * | 1996-10-01 | 2012-03-20 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| US8853260B2 (en) | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| HUP9701554D0 (en) * | 1997-09-18 | 1997-11-28 | Human Oltoanyagtermeloe Gyogys | Pharmaceutical composition containing plazma proteins |
| WO2000047187A1 (en) * | 1999-02-11 | 2000-08-17 | Kinetana Inc. | Serum albumin-based parenteral formulations of polyene macrolides |
| EP1216059B1 (en) | 1999-09-16 | 2005-10-19 | Novo Nordisk A/S | Composition for ivf |
| US6569459B2 (en) * | 2000-04-10 | 2003-05-27 | Teva Pharmaceutical Industries, Ltd. | Method of administration of paclitaxel-plasma protein formulation |
| CZ20023333A3 (cs) * | 2000-04-10 | 2003-06-18 | Teva Pharmaceutical Industries Ltd. | Léčivo pro léčení rakoviny |
| WO2002087563A2 (en) * | 2001-05-01 | 2002-11-07 | Angiotech Pharmaceuticals Inc. | Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions |
| CA2471363C (en) | 2001-12-21 | 2014-02-11 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| GR1004274B (el) | 2002-07-16 | 2003-06-23 | Medexis ���� | Συμπλοκα στεροειδων ορμονων με πρωτεινες: νεες ουσιες για την ειδικη ανιχνευση και καταστροφη καρκινικων κυτταρων προερχομενων απο στερεους ογκους και αιματολογικες κακοηθειες |
| BR0312690A (pt) | 2002-07-16 | 2005-05-03 | Medexis S A | Conjugados esteróides, sua preparação e seu uso |
| AU2003262025A1 (en) * | 2002-09-12 | 2004-04-30 | Nihon Medi-Physics Co., Ltd. | Preparation for controlling binging of drug to plasma protein |
| TR200502189T1 (tr) * | 2002-12-09 | 2007-01-22 | American Bioscience, Inc. | Kompozisyonlar ve farmakolojik etken maddelerin aktarımı için yöntemler. |
| WO2004101620A2 (en) * | 2003-05-01 | 2004-11-25 | Compound Therapeutics, Inc. | Serum albumin scaffold-based proteins and uses thereof |
| US20040225022A1 (en) * | 2003-05-09 | 2004-11-11 | Desai Neil P. | Propofol formulation containing reduced oil and surfactants |
| US7345093B2 (en) | 2004-04-27 | 2008-03-18 | Formatech, Inc. | Methods of enhancing solubility of compounds |
| US7659310B2 (en) | 2004-04-27 | 2010-02-09 | Formatech, Inc. | Methods of enhancing solubility of agents |
| US20050277584A1 (en) * | 2004-06-09 | 2005-12-15 | Allergan, Inc. | Pharmaceutical compositions comprising cyclosporins |
| EP1804609A2 (en) * | 2004-09-29 | 2007-07-11 | Tel Hashomer Medical Research Infrastructure and Services Ltd. | Monitoring of convection enhanced drug delivery |
| US20060198891A1 (en) * | 2004-11-29 | 2006-09-07 | Francois Ravenelle | Solid formulations of liquid biologically active agents |
| US7507842B2 (en) | 2005-08-12 | 2009-03-24 | Radiorx, Inc. | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof |
| ES2400964T3 (es) | 2007-04-04 | 2013-04-15 | Sigmoid Pharma Limited | Composiciones famacéuticas de ciclosporina |
| WO2008132707A1 (en) | 2007-04-26 | 2008-11-06 | Sigmoid Pharma Limited | Manufacture of multiple minicapsules |
| JPWO2009116557A1 (ja) * | 2008-03-21 | 2011-07-21 | 富士フイルム株式会社 | 薬剤含有組成物 |
| CN101658516B (zh) * | 2008-08-26 | 2011-10-05 | 齐鲁制药有限公司 | 紫杉醇类药物组合物及其制备方法 |
| CN102470106B (zh) | 2009-05-18 | 2015-09-23 | 希格默伊德药业有限公司 | 包含油滴的组合物 |
| IN2012DN00781A (sl) | 2009-08-12 | 2015-06-26 | Sigmoid Pharma Ltd | |
| EP2480208A1 (en) | 2009-09-23 | 2012-08-01 | Indu Javeri | Methods for the preparation of liposomes |
| US10143652B2 (en) | 2009-09-23 | 2018-12-04 | Curirx Inc. | Methods for the preparation of liposomes |
| US9629920B2 (en) | 2009-12-18 | 2017-04-25 | Exodos Life Sciences Limited Partnership | Methods and compositions for stable liquid drug formulations |
| EP2531173B1 (en) * | 2010-02-03 | 2018-09-26 | Oncbiomune, L.L.C. | Taxane- and taxoid-protein compositions |
| AR093275A1 (es) | 2010-03-17 | 2015-05-27 | Centro De Excelencia En Productos Y Procesos De Cordoba (Ceprocor) | Una composicion farmaceutica soluble en agua que comprende al menos una sustancia terapeuticamente activa de caracteristicas hidrofobicas y al menos un compuesto seleccionado entre los sialoglicoesfingolipidos, los glicoesfingolipidos o una mezcla de sialoglicoesfingolipidos y glicoesfingolipidos |
| GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
| GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
| GB201319791D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
| EP3119391A4 (en) * | 2014-03-18 | 2017-12-27 | Izun Pharmaceuticals Corp. | Protein-bound cannabinoid compositions |
| ES2858517T3 (es) | 2014-11-07 | 2021-09-30 | Sublimity Therapeutics Ltd | Composiciones que comprenden ciclosporina |
| AR100034A1 (es) | 2015-01-30 | 2016-09-07 | Consejo Nac De Investig Científicas Y Técnicas (Conicet) | Una composición farmacéutica soluble en agua que comprende, al menos, una sustancia terapéuticamente activa y, al menos, una sustancia con capacidad para formar micelas |
| US10071141B2 (en) | 2015-05-08 | 2018-09-11 | Spectral Platforms, Inc. | Albumin-based non-covalent complexes and methods of use thereof |
| JP2018527287A (ja) | 2015-05-15 | 2018-09-20 | アルブヴェックス エルエルシー | ドセタキセルおよびヒト血清アルブミンの複合体 |
| AU2016280276A1 (en) * | 2015-06-18 | 2017-12-07 | Matinas Biopharma Nanotechnologies, Inc. | Compositions and methods for treating inflammatory disease or conditions |
| WO2017083397A1 (en) * | 2015-11-09 | 2017-05-18 | Cayo Max A | Cardiac glycosides for the treatment of hypercholesterolemia |
| EP4019023A1 (en) * | 2016-08-03 | 2022-06-29 | Zhuhai Beihai Biotech Co., Ltd. | Formulations of fosaprepitant and aprepitant |
| CN115487312A (zh) | 2016-10-27 | 2022-12-20 | 珠海贝海生物技术有限公司 | 多西他赛和人血清白蛋白的中性pH组合物 |
| US11105747B2 (en) | 2017-03-20 | 2021-08-31 | Spectral Platforms, Inc. | Spectroscopic methods to detect and characterize microorganisms |
| IL271777B1 (en) | 2017-07-07 | 2024-05-01 | Epicentrx Inc | Preparations for intravenous administration of medical substances |
| BR112020017988A2 (pt) | 2018-03-09 | 2020-12-22 | Panoptes Pharma Ges.M.B.H. | Composição oftálmica |
| EP3811982A1 (en) * | 2019-10-25 | 2021-04-28 | Université de Strasbourg | Protein-based biomaterial with viscoelastic behaviour, process for obtaining it and uses thereof |
| CN111529506B (zh) * | 2020-05-18 | 2021-09-03 | 同济大学 | 一种两性霉素b白蛋白纳米制剂及其制备方法和应用 |
| US11739166B2 (en) | 2020-07-02 | 2023-08-29 | Davol Inc. | Reactive polysaccharide-based hemostatic agent |
| CN114544926A (zh) * | 2021-12-02 | 2022-05-27 | 浙江鑫科医疗科技有限公司 | 一种血清蛋白稳定剂 |
| CN115236216B (zh) * | 2022-06-07 | 2024-03-01 | 合肥和合医疗科技有限公司 | 高效液相色谱串联质谱检测全血中免疫抑制剂的试剂盒，其制备方法和检测方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4833013A (sl) * | 1971-08-30 | 1973-05-07 | ||
| DE2653534C2 (de) * | 1975-12-22 | 1986-08-28 | Baxter Travenol Laboratories, Inc., Deerfield, Ill. | Feste Antihämophilen-Faktor-Präparation und Verfahren zu ihrer Herstellung |
| JPS58216126A (ja) * | 1982-06-11 | 1983-12-15 | Ono Pharmaceut Co Ltd | 可容化製剤 |
| DE3702105A1 (de) * | 1987-01-24 | 1988-08-04 | Bayer Ag | Parenterale loesung |
| JPS63215640A (ja) * | 1987-03-04 | 1988-09-08 | Nippon Hai Potsukusu:Kk | 易吸収性抗炎症剤及びその製造方法 |
| WO1988006457A1 (en) * | 1987-03-04 | 1988-09-07 | Nippon Hypox Laboratories Incorporated | Medicinal composition containing albumin as carrier and process for its preparation |
| CA2086874E (en) | 1992-08-03 | 2000-01-04 | Renzo Mauro Canetta | Methods for administration of taxol |
| US5356927A (en) * | 1992-12-02 | 1994-10-18 | Thomas Jefferson University | Methods of treating plasmodium and babesia parasitic infections |
| US5916596A (en) * | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| US5439686A (en) | 1993-02-22 | 1995-08-08 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor |
| GB9510716D0 (en) * | 1995-05-26 | 1995-07-19 | Pharmacia Spa | Substituted camptothecin derivatives and process for their preparation |
| TR199600775A2 (tr) | 1996-09-27 | 1997-09-21 | Tureks Turunc Madencilik Ic Ve | Taslara eskitilmis görüntü kazandirilmasi icin bir yöntem. |
| US5776912A (en) * | 1996-12-20 | 1998-07-07 | Schering Corporation | Lipophilic oligosaccharide antibiotic compositions |
| HUP9701554D0 (en) * | 1997-09-18 | 1997-11-28 | Human Oltoanyagtermeloe Gyogys | Pharmaceutical composition containing plazma proteins |
| ITMI20001107A1 (it) * | 2000-05-18 | 2001-11-18 | Acs Dobfar Spa | Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel |
-
1997
- 1997-09-18 HU HU9701554A patent/HUP9701554D0/hu unknown
-
1998
- 1998-09-10 HR HRP9701554A patent/HRP980499A2/hr not_active Application Discontinuation
- 1998-09-17 CZ CZ20000952A patent/CZ301326B6/cs not_active IP Right Cessation
- 1998-09-17 SK SK329-2000A patent/SK284683B6/sk not_active IP Right Cessation
- 1998-09-17 ES ES98946629T patent/ES2187062T3/es not_active Expired - Lifetime
- 1998-09-17 KR KR1020007002810A patent/KR100587962B1/ko not_active IP Right Cessation
- 1998-09-17 RS YUP-166/00A patent/RS50102B/sr unknown
- 1998-09-17 CA CA002269923A patent/CA2269923C/en not_active Expired - Lifetime
- 1998-09-17 PL PL339369A patent/PL193067B1/pl unknown
- 1998-09-17 IL IL13505598A patent/IL135055A/en not_active IP Right Cessation
- 1998-09-17 DE DE69810612T patent/DE69810612T2/de not_active Expired - Lifetime
- 1998-09-17 BR BR9812469-2A patent/BR9812469A/pt not_active Application Discontinuation
- 1998-09-17 JP JP51757699A patent/JP2001508806A/ja not_active Withdrawn
- 1998-09-17 SI SI9820067A patent/SI20189B/sl active Search and Examination
- 1998-09-17 EA EA200000331A patent/EA004700B1/ru not_active IP Right Cessation
- 1998-09-17 AT AT98946629T patent/ATE230611T1/de active
- 1998-09-17 PT PT98946629T patent/PT981375E/pt unknown
- 1998-09-17 NZ NZ503302A patent/NZ503302A/en unknown
- 1998-09-17 AU AU93623/98A patent/AU734695B2/en not_active Ceased
- 1998-09-17 CN CNB988092514A patent/CN1189216C/zh not_active Expired - Fee Related
- 1998-09-17 RO ROA200000315A patent/RO118695B1/ro unknown
- 1998-09-17 TR TR2000/01545T patent/TR200001545T2/xx unknown
- 1998-09-17 WO PCT/HU1998/000086 patent/WO1999013914A1/en not_active Application Discontinuation
- 1998-09-17 DK DK98946629T patent/DK0981375T3/da active
- 1998-09-17 EP EP98946629A patent/EP0981375B1/en not_active Expired - Lifetime
- 1998-09-18 AR ARP980104659A patent/AR017120A1/es not_active Application Discontinuation
- 1998-09-18 ZA ZA9808585A patent/ZA988585B/xx unknown
- 1998-09-18 TW TW087115619A patent/TWI222365B/zh not_active IP Right Cessation
-
1999
- 1999-04-27 US US09/299,562 patent/US6743826B1/en not_active Expired - Lifetime
-
2000
- 2000-03-14 LV LVP-00-38A patent/LV12493B/en unknown
- 2000-03-16 BG BG104245A patent/BG64749B1/bg unknown
- 2000-03-16 NO NO20001371A patent/NO325294B1/no not_active IP Right Cessation
- 2000-03-17 LT LT2000018A patent/LT4736B/lt not_active IP Right Cessation
-
2003
- 2003-01-21 US US10/349,492 patent/US7119124B2/en not_active Expired - Lifetime
-
2004
- 2004-03-17 US US10/802,528 patent/US7501455B2/en not_active Expired - Fee Related
-
2006
- 2006-10-10 US US11/546,518 patent/US20070232536A1/en not_active Abandoned
-
2009
- 2009-02-09 US US12/322,997 patent/US8946167B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA988585B (en) | Pharmaceutical compositions containing plasma protein. | |
| HK1022271A1 (en) | Pharmaceutical aerosol composition. | |
| HK1027957A1 (en) | Pharmaceutical composition. | |
| GB9727053D0 (en) | Pharmaceutical compositions | |
| GB9706089D0 (en) | Pharmaceutical composition | |
| CY2569B1 (en) | Pharmaceutical compositions | |
| AU8107998A (en) | Pharmaceutical compositions | |
| ZA989680B (en) | Pharmaceutical composition. | |
| AU7904998A (en) | Pharmaceutical composition containing peptichemio | |
| IL114673A0 (en) | Pharmaceutical compositions containing protein | |
| IL131995A0 (en) | Gastric-retained pharmaceutical compositions | |
| ZA987392B (en) | Pharmaceutical composition. | |
| GB9723985D0 (en) | Pharmaceutical compositions | |
| HUP0004669A3 (en) | Pharmaceutical compositions | |
| HU9700632D0 (en) | Pharmaceutical compositions | |
| AU1509799A (en) | Pharmaceutical composition containing cyclosporin | |
| AU8817498A (en) | Pharmaceutical composition containing midazolam | |
| GB2321190B (en) | Pharmaceutical composition | |
| ZA982117B (en) | Pharmaceutical compositions | |
| ZA982367B (en) | Pharmaceutical compositions. | |
| HU9802107D0 (en) | Pharmaceutical composition containing plazma proteins | |
| GB9722066D0 (en) | Pharmaceutical compositions | |
| GB9714328D0 (en) | Pharmaceutical compositions | |
| GB9725563D0 (en) | Pharmaceutical compositions | |
| GB9714081D0 (en) | Pharmaceutical compositions |